Insider Buying: Lifevantage (NASDAQ:LFVN) Director Acquires 10,500 Shares of Stock

Lifevantage Corporation (NASDAQ:LFVN) Director Judd Dayton bought 10,500 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were bought at an average cost of $4.53 per share, for a total transaction of $47,565.00. Following the transaction, the director directly owned 80,359 shares in the company, valued at approximately $364,026.27. This represents a 15.03% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Judd Dayton also recently made the following trade(s):

• On Friday, February 27th, Judd Dayton acquired 18,097 shares of Lifevantage stock. The shares were bought at an average price of $4.63 per share, with a total value of $83,789.11.
• On Thursday, February 26th, Judd Dayton acquired 4,600 shares of Lifevantage stock. The shares were bought at an average cost of $4.58 per share, for a total transaction of $21,068.00.

Lifevantage Stock Performance

LFVN traded down $0.13 on Monday, hitting $4.52. The company had a trading volume of 155,943 shares, compared to its average volume of 238,601. The stock has a market capitalization of $57.82 million, a price-to-earnings ratio of 7.53 and a beta of 0.33. The stock has a fifty day moving average price of $5.64 and a 200-day moving average price of $7.92. Lifevantage Corporation has a 12-month low of $3.90 and a 12-month high of $17.64.

Lifevantage (NASDAQ:LFVN) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.07). The firm had revenue of $48.93 million during the quarter, compared to the consensus estimate of $54.40 million. Lifevantage had a net margin of 3.74% and a return on equity of 29.59%. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a dividend of $0.045 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.18 dividend on an annualized basis and a dividend yield of 4.0%. Lifevantage’s dividend payout ratio is presently 30.00%.

Wall Street Analyst Weigh In

LFVN has been the topic of several research analyst reports. Lake Street Capital restated a “buy” rating on shares of Lifevantage in a research note on Thursday, February 5th. Wall Street Zen lowered Lifevantage from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Loop Capital set a $5.00 price objective on shares of Lifevantage in a research report on Thursday, February 5th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Lifevantage in a research note on Monday, December 29th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Lifevantage presently has a consensus rating of “Moderate Buy” and a consensus target price of $5.00.

Hedge Funds Weigh In On Lifevantage

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Police & Firemen s Retirement System of New Jersey purchased a new position in Lifevantage during the 2nd quarter worth approximately $31,000. JPMorgan Chase & Co. increased its stake in shares of Lifevantage by 870.2% in the second quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock worth $66,000 after acquiring an additional 4,499 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Lifevantage in the second quarter worth $76,000. BNP Paribas Financial Markets raised its holdings in shares of Lifevantage by 2,555.8% during the second quarter. BNP Paribas Financial Markets now owns 6,135 shares of the company’s stock worth $80,000 after purchasing an additional 5,904 shares during the last quarter. Finally, Cubist Systematic Strategies LLC acquired a new position in Lifevantage during the first quarter valued at $97,000. Institutional investors and hedge funds own 35.32% of the company’s stock.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.